Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 9 Hematopoietic and Lymphatic System Neoplasm 7 Prostatic Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Urinary Bladder Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Ovarian Neoplasms 3 Hematopoietic and Lymphoid System Neoplasm 3 Hematologic Neoplasms 3 Colorectal Neoplasms 3 Breast Neoplasms 3 Triple Negative Breast Neoplasms 2 Mouth Neoplasms 2 Melanoma 2 Malignant Solid Neoplasm 2 Head and Neck Carcinoma 2 Fallopian Tube Neoplasms 2 Vulvar Neoplasms 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urogenital Neoplasms 1 Ureteral Neoplasms 1 Tonsillar Neoplasms 1 Tongue Neoplasms 1 Teratoma 1 Stomatitis 1 Spondylitis, Ankylosing 1 Psoriasis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Peritoneal Neoplasms 1

Interventions

Oxaliplatin 5 Mitomycin 4 Hyperthermic Intraperitoneal Chemotherapy 4 Fluorouracil 4 Cisplatin 4 Paclitaxel 3 Doxorubicin 3 Standard of Care 2 Leucovorin 2 Docetaxel 2 Blood Specimen Collection 2 Bevacizumab 2 sodium thiosulfate 1 relacorilant 1 liposomal doxorubicin 1 irinotecan sucrosofate 1 dehydroftorafur 1 X-Rays 1 Topotecan 1 Specimen Handling 1 Practice Guidelines as Topic 1 Platinum 1 Pancreatectomy 1 Pafolacianine 1 Observation 1 Mitozytrex 1 Magnetic Resonance Spectroscopy 1 Letrozole 1 Laparoscopy 1 LY-2157299 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Peritoneal Neoplasms × Practice Guidelines as Topic × Clear all

NCT07001748 2026-05-15

STOPGAP II

Eastern Cooperative Oncology Group

Phase 2/3 Recruiting

Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡